Exploratory analysis from Phase 1b/2 breast cancer trial reinforces CD47 as a predictive biomarker for response, as previously observed in the ...
Exploratory Factor Analysis (EFA) is a pivotal statistical approach that enables researchers to uncover latent structures in complex datasets, a process that is increasingly integral to higher ...
WHIPPANY, N.J.--(BUSINESS WIRE)--The study design and baseline characteristics of FINE-HEART, a new prespecified, exploratory pooled analysis of three Phase III trials with finerenone 1, were ...
New biomarker analyses from the phase 3 KEYNOTE-522 trial provide insights into the biological factors that may influence response to pembrolizumab plus chemotherapy in early-stage triple-negative ...
Atlanta and Tel Aviv — February 14, 2023 – Intelligent monitoring platform maker Mona has announced an automated exploratory data analysis tool to identify the root-cause of anomalies in multivariate ...
SAN DIEGO — An analysis comparing patient-level data from two recent phase 3 trials demonstrated an approximately 40% reduction in the risk for non–small cell lung cancer (NSCLC) recurrence or death ...
Capivasertib (C) and fulvestrant (F) for patients (pts) with aromatase inhibitor (AI)-resistant HR+/HER2– advanced breast cancer (ABC): Characterization and management of common adverse events (AEs) ...
The U S. Federal Reserve included a new facet of its annual stress test designed to explore "additional hypothetical risks" to the banking system. This year, the Fed studied the rapid repricing of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results